Drugs / Smac Mimetic LCL161
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01955434 | Nov 2013 → Jun 2016 | plasma cell myeloma | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Smac Mimetic LCL161 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01955434 ↗ |
| Modality | Other / unclassified | “SMAC mimetic LCL161” NCT01955434 ↗ |
| Route | Oral | “Given PO” NCT01955434 ↗ |